Curative Biotechnology, Inc. (CUBT)

Curative Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.06	0.06	0.67	0.16	-
Cash & Short-Term Investments	0.06	0.06	0.67	0.16	-
Cash Growth	-3.87%	-91.25%	317.33%	-	-
Other Receivables	0.12	-	0.03	-	-
Receivables	0.12	-	0.03	-	-
Prepaid Expenses	0.43	-	0.06	1.9	-
Other Current Assets	-	-	-	0.07	-
Total Current Assets	0.6	0.06	0.75	2.13	-
Property, Plant & Equipment	0.01	0.01	0.01	0	0
Other Intangible Assets	1.42	1.51	1.56	0.14	0.04
Long-Term Deferred Charges	0.57	0.49	0.09	-	-
Total Assets	2.6	2.06	2.41	2.27	0.04
Accounts Payable	3.49	3.43	0.73	0.1	-
Short-Term Debt	2.26	1.12	-	0.56	0.12
Other Current Liabilities	-	0.04	0	0.01	-
Total Current Liabilities	5.75	4.6	0.73	0.66	0.12
Total Liabilities	5.75	4.6	0.73	0.66	0.12
Common Stock	0.09	0.06	0	0	0.03
Additional Paid-In Capital	34.99	29.81	10.56	3.58	3.3
Retained Earnings	-38.23	-32.41	-26.92	-8.1	-3.42
Total Common Equity	-3.15	-2.54	-16.36	-4.52	-0.09
Shareholders' Equity	-3.14	-2.54	1.68	1.61	-0.09
Total Liabilities & Equity	2.6	2.06	2.41	2.27	0.04
Total Debt	2.26	1.12	-	0.56	0.12
Net Cash (Debt)	-2.2	-1.07	0.67	-0.4	-0.12
Net Cash Per Share	-0.00	-0.00	0.00	-0.00	-0.00
Filing Date Shares Outstanding	903.26	572.01	571.65	544.79	322.8
Total Common Shares Outstanding	903.26	572.01	570.65	333	322.8
Working Capital	-5.14	-4.54	0.02	1.47	-0.12
Book Value Per Share	-0.00	-0.00	-0.03	-0.01	-0.00
Tangible Book Value	-4.57	-4.05	-17.92	-4.66	-0.13
Tangible Book Value Per Share	-0.01	-0.01	-0.03	-0.01	-0.00

Updated Nov 30, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.